These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

613 related items for PubMed ID: 16322345

  • 1. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.
    Panzuto F, Nasoni S, Falconi M, Corleto VD, Capurso G, Cassetta S, Di Fonzo M, Tornatore V, Milione M, Angeletti S, Cattaruzza MS, Ziparo V, Bordi C, Pederzoli P, Delle Fave G.
    Endocr Relat Cancer; 2005 Dec; 12(4):1083-92. PubMed ID: 16322345
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study.
    Elias D, Lasser P, Ducreux M, Duvillard P, Ouellet JF, Dromain C, Schlumberger M, Pocard M, Boige V, Miquel C, Baudin E.
    Surgery; 2003 Apr; 133(4):375-82. PubMed ID: 12717354
    [Abstract] [Full Text] [Related]

  • 4. Gastroenteropancreatic neuroendocrine tumors: incidence and treatment outcome in a single institution in Korea.
    Lim T, Lee J, Kim JJ, Lee JK, Lee KT, Kim YH, Kim KW, Kim S, Sohn TS, Choi DW, Choi SH, Chun HK, Lee WY, Kim KM, Jang KT, Park YS.
    Asia Pac J Clin Oncol; 2011 Sep; 7(3):293-9. PubMed ID: 21884442
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
    Fendrich V, Habbe N, Celik I, Langer P, Zielke A, Bartsch DK, Rothmund M.
    Dtsch Med Wochenschr; 2007 Feb 02; 132(5):195-200. PubMed ID: 17252361
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.
    Bilimoria KY, Bentrem DJ, Merkow RP, Tomlinson JS, Stewart AK, Ko CY, Talamonti MS.
    J Am Coll Surg; 2007 Oct 02; 205(4):558-63. PubMed ID: 17903729
    [Abstract] [Full Text] [Related]

  • 10. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S, Johnson MM, Murthy R, Ahrar K, Wallace MJ, Madoff DC, McRae SE, Hicks ME, Rao S, Vauthey JN, Ajani JA, Yao JC.
    Cancer; 2005 Oct 15; 104(8):1590-602. PubMed ID: 16134179
    [Abstract] [Full Text] [Related]

  • 11. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
    Pape UF, Jann H, Müller-Nordhorn J, Bockelbrink A, Berndt U, Willich SN, Koch M, Röcken C, Rindi G, Wiedenmann B.
    Cancer; 2008 Jul 15; 113(2):256-65. PubMed ID: 18506737
    [Abstract] [Full Text] [Related]

  • 12. The significance of CD44 expression in gastrointestinal neuroendocrine tumors.
    Lai CH, Shan YS, Sy ED, Hsieh YH, Tsai HW, Lee JC, Lin PW.
    Hepatogastroenterology; 2005 Jul 15; 52(64):1071-6. PubMed ID: 16001632
    [Abstract] [Full Text] [Related]

  • 13. Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung).
    Kim SJ, Kim JW, Oh DY, Han SW, Lee SH, Kim DW, Im SA, Kim TY, Heo DS, Bang YJ.
    Am J Clin Oncol; 2012 Dec 15; 35(6):549-56. PubMed ID: 21659833
    [Abstract] [Full Text] [Related]

  • 14. Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features.
    Faggiano A, Sabourin JC, Ducreux M, Lumbroso J, Duvillard P, Leboulleux S, Dromain C, Colao A, Schlumberger M, Baudin E.
    Cancer; 2007 Jul 15; 110(2):265-74. PubMed ID: 17569104
    [Abstract] [Full Text] [Related]

  • 15. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified?
    Ferrone CR, Tang LH, Tomlinson J, Gonen M, Hochwald SN, Brennan MF, Klimstra DS, Allen PJ.
    J Clin Oncol; 2007 Dec 10; 25(35):5609-15. PubMed ID: 18065733
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma.
    Durante C, Boukheris H, Dromain C, Duvillard P, Leboulleux S, Elias D, de Baere T, Malka D, Lumbroso J, Guigay J, Schlumberger M, Ducreux M, Baudin E.
    Endocr Relat Cancer; 2009 Jun 10; 16(2):585-97. PubMed ID: 19240182
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, Gullerud RE, Donohue JH, Nagorney DM, Farnell MB.
    Ann Surg; 2008 Mar 10; 247(3):456-62. PubMed ID: 18376190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.